http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0806666-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dcb1d0954d254af3de34cb2df4bfd93
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2300-0825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2300-0887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2400-0406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2300-0681
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54388
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L3-5023
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01L9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01L3-00
filingDate 1997-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_509638a3d374335f1920884cf22279c8
publicationDate 1997-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0806666-A2
titleOfInvention Method and apparatus for single step assays of whole blood
abstract The invention consists of devices for use in assaying fluid test samples for analyte of interest wherein the samples contain or are suspected of containing cells and cellular components. The devices of the invention each include a hydrophilic cell trap (1) for separation of the cellular fraction from the noncellular fraction of the test sample. The latter fraction migrates through porous, absorbent or bibulous membranes (3, 15, 20) of the device which are impregnated with reagents in at least three separate zones comprising a dye zone (15), a test zone (21) and a control zone (22). Formation of a distinctive visual pattern in the control zone indicates that the test was competently performed while formation or relative intensity of the visual pattern in the test zone indicates presence or absence of analyte in the test sample. The devices of the invention are particularly suited for assaying ligands in whole blood without prior separation of erythrocytes and other cells from the blood and without need to measure reflectance in the liquid phase. A method for performing the inventive assays is also disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1023600-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BE-1011487-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9164087-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1023600-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03012443-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10871428-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8303908-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9291620-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012012500-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0129558-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8025850-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2148743-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010119380-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2148743-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2801386-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10610862-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3807000-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0191903-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9918439-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0191903-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8252139-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8062608-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1538444-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7850909-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0006702-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0136964-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0136964-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0977032-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0973034-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03012443-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8287817-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0977032-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10088397-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2528657-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7531362-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9079179-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100427950-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2528657-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007000048-A1
priorityDate 1996-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4883764-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0045476-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5384264-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705

Total number of triples: 69.